Abstract
The aim of the study included the development and refinement of the technique of stereotaxic cryoablation to improve the safety and radicalness of the procedure. Cryoablation was performed in 56 patients with a histologically confirmed diagnosis of renal cell carcinoma in 65.5% of patients, its chromophobic variant - in 10.4% of the rest - oncocytoma. Local recurrence was detected in four patients with initial tumor sizes over 30 cm3, who required repeated cryoablation for complete tumor devitalization. We used Russian minimally invasive cryosurgical systems "MKS" with liquid nitrogen, a set of special tools and reusable cryoprobes with a needle diameter of 1.5 mm to 3.0 mm. The planning of procedure includes projections of the contours of the ice spheres of different cryoprobes were superimposed on the three-dimensional CT image of the tumor, simulating the complete coverage of the tumor by a common ice-balls with the capture of at least 3 mm of kidney tissue and up to 10 mm of perinephric fat. Two navigation options were used during procedure: free or robotic with a navigation CT attachment. In the lumbar region in the zone of surgical approaches were determined directrix. The directrix - it is one or more sectors for the introduction of instruments and cryoprobes. The angle and depth of each directrix depended on the location of the tumor. After controlling the position of the cryoprobes in the CT room or operating room were performed two cooling cycles with passive thawing, direct thermometry, automatic exposure retention, and visual assessment of the completeness of tumor glaciation The hematoma after using cryoprobes of 3 mm did not exceed 150 ml and not require additional intervention. The proposed technology ensured the safety and efficiency of precision cryoablation of kidney tumors, thanks to accurate navigation, high power of modern minimally invasive cryogenic equipment and additional training of specialists.
References
Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России. под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. 2021:252 [Malignant neoplasms in Russia in 2020 (morbidity and mortality). AD Kaprin, VV Starinsky, AO Shakhzadova (Eds). M.: P.A. Herzen - branch of the Federal State Budgetary Institution "NMITs Radiology" of the Ministry of Health of Russia. 202:252 (In Russ.)].
Piasentin A, Claps F, Silvestri T, et al. Trifecta achievement after percutaneous cryoablation of small renal masses: results from a multi-institutional collaboration. Medicina (Kaunas). 2022;58(8):1041. doi:10.3390/medicina58081041.
Zargar H, Atwell TD, Cadeddu JA, et al. Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol. 2016;69(1):11628. doi:10.1016/j.eururo.2015.03.027.
Marcove RC, Sadrieh J, Huvos AG, et al. Cryosurgery in the treatment of solitary or multiple bone metastases from renal cell carcinoma. J Urol. 1972 Oct;108(4):5407. doi:10.1016/s0022-5347(17)60797-3.
Sindelar WF, Javadpour N, Bagley DH. Histological and ultrastructural changes in rat kidney after cryosurgery. J Surg Oncol. 1981;18(4):36379. doi:10.1002/jso.2930180406.
Рубрикатор клинических рекомендаций. Министерство здравоохранения Российской Федерации. Клинические рекомендации «Рак паренхимы почки», год утверждения 2022. [Clinical Guidelines Catalog. Ministry of Health of the Russian Federation. Clinical Guidelines "Renal Parenchymal Cancer", approved in 2022 (In Russ.)]. Available from: https://cr.minzdrav.gov.ru/recomend/10_3.
Балахнин П.В., Шмелев А.С., Шачинов Е.Г., и др. Чрескожная ангиографически-ассистированная криоаблация почечно-клеточного рака под контролем плоскодетекторной компьютерной томографии: возможности и потенциальные преимущества технологии. Онкологический журнал: лучевая диагностика, лучевая терапия. 2021;4(4):5677 [Balakhnin PV, Shmelev AS, Shachinov EG, et al. Percutaneous angiographic-assisted cryoablation of renal cell carcinoma under the control of flat-detector computed tomography: possibilities and potential advantages of the technology. Journal of Oncology: Radiation Diagnostics, Radiation Therapy. 2021;4(4):5677 (In Russ.)].
Глыбочко П.В., Аляев Ю.Г., Рапопорт Л.М., Амосов А.В. и др. Возможность использования местной анестезии при чрескожной криоаблации почечно-клеточного рака под УЗ-контролем. Онкоурология. 2018;14(2):2732 [Glybochko PV, Alyaev YuG, Rapoport LM, Amosov AV, et al. Possibility of using local anesthesia for percutaneous cryoablation of renal cell carcinoma under ultrasound control. Oncourology, 2018;14(2):2732 (In Russ.)].
Auer T, Heidegger I, Zordo T, et al. Fusion imaging of contrast-enhanced ultrasound with CT or MRI for kidney lesions. In Vivo. 2019;33(1):203208. doi:10.21873/invivo.11460.
Abushamma F, Barqawi A, Al-Jabi SW. Global analysis of research trends on kidney function after nephron-sparing surgery: A bibliometric and visualised study. Cancer Manag Res. 2021;13:74797487. doi:10.2147/CMAR.S324284.
Breen DJ, King AJ, Patel N, et al. Image guided cryoablation for sporadic renal cell carcinoma: three- and 5 year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology. 2018;289:554–561. doi:10.1148/radiol.2018180249.
Franco L. Cryosurgery for renal cancer. Modern Cryosurgery for Cancer. 2012;649–80. doi:10.1142/9789814329668_0035.
Prokhorov GG, Gasanov MI, Klepikov VV, et al. A minimally invasive cryotherapeutic system. Biomedical Engineering. 2017;51(1):4155.
Андреев Н.А., Васильев А.О., Морозова Н.В., и др. Многозондовая малоинвазивная криоаблация. Высокотехнологическая медицина. 2019;6(1);2130 [Andreev NA, Vasiliev AO, Morozova NV, et al. Multiprobe minimally invasive cryoablation. High-tech medicine. 2019;6(1);2130 (In Russ.)].
Gunn AJ, Joe WB, Salei A, et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: safety, technical results, and clinical outcomes. Cardiovasc Intervent Radiol. 2019;42:970–978. doi:10.1007/s00270-019-02226-5.
Zhou W, Herwald SE, McCarthy C, et al. Radiofrequency ablation, cryoablation, and microwave ablation for t1a renal cell carcinoma: a comparative evaluation of therapeutic and renal function outcomes. J Vasc Interv Radiol. 2019;30:1035–1042. doi:10.1016/j.jvir.2018.12.013.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2023